Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Exp Clin Psychopharmacol. 2020 Mar 19;29(1):59–72. doi: 10.1037/pha0000351

Table 2.

Sample Characteristics by Group from Study 2 (N=255)

Frequency (% within group)
Characteristics Health goal EFT n=63 Health goal ERT n=60 EFT-general n=61 ERT-general n=71 P value
BMI Mean (SD) 39.2 (14.63) 36.4 (6.94) 35.7 (4.86) 37.5 (8.38) .054
Age Mean (SD) 37.5 (11.92) 36.1 (10.38) 37.2 (10.33) 35.8 (11.61) .985
Female 39 (61.9) 37 (61.7) 39 (65.0)a 36 (50.7) .348
White 53 (84.1) 51 (85.0) 48 (80.0)a 54 (76.1) .532
Non-Hispanic or Latino 59 (93.6) 57 (95.0) 55 (93.2)aa 64 (91.4)a .879
Education level .713
 HS diploma/equiv. 5 (7.9) 6 (10.0) 4 (6.6) 4 (5.6)
 Some college/2-yr deg. 21 (33.3) 25 (41.7) 27 (44.3) 24 (33.8)
 4-yr deg./higher 36 (57.1) 29 (48.3) 30 (49.2) 43 (60.6)
Income .432
 $0 – $29,999 13 (20.6) 16 (26.7) 12 (19.7) 20 (28.2)
 $30,000 – $69,999 33 (52.4) 29 (48.3) 31 (50.8) 25 (35.2)
 $70,000 and greater 17 (27.0) 15 (25.0) 18 (29.5) 26 (36.6)
 Cue characteristics Mean (SD)
 Valence 4.29 (.66) 4.31(61) 4.27 (.63) 4.31 (.53) .985
 Salience 3.85 (.96) 3.99 (.82) 3.64 (1.04) 3.76 (1.02) .240
 Arousal 3.87 (.84) 3.97 (.72) 3.70 (.90) 3.72 (.96) .258
 Vividness 4.39 (.67) 4.43 (.64) 4.21 (.81) 4.29 (.61) .261

HS: High School

a

One participant chose not to report

aa

Two participants chose not to report